Email: cspc@cspc.cn
Media
News Center
Oct. 09
2025
VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Sep. 30
VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Sep. 25
VOLUNTARY ANNOUNCEMENT - LECANEMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Sep. 12
VOLUNTARY ANNOUNCEMENT - SYH2066 TABLETS OBTAIN CLINICAL TRIAL APPROVAL IN CHINA
Sep. 11
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR KN026 (ANBENITAMAB INJECTION) ACCEPTED BY THE NMPA
Aug. 22
VOLUNTARY ANNOUNCEMENT - SYS6036 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
